Looks like it was just the one holder who needed to liquidate some funds....
Stopped any forward momentum for sure, but a sniff of a successful GMP and away we go, anything but a success is not wrth the energy as we all know where we will be...
Trials in q4 and ALL the Ann's that will come with that before hand should does us all well, also i am a believer that DX-3 will be partnered and brought back into play once scale up of DX-1 is proved up.
Ann: Presentation to highlight broader potential of Deoxymabs, page-55
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.8¢ |
Change
-0.001(6.25%) |
Mkt cap ! $15.43M | |||
| Open | High | Low | Value | Volume |
| 0.8¢ | 0.8¢ | 0.8¢ | $4.313K | 575K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 26 | 8536128 | 0.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.8¢ | 2418923 | 6 |
View Market Depth
| Last trade - 13.50pm 22/05/2024 (20 minute delay) ? |
|
|||||
|
Last
0.8¢ |
Change
-0.001 ( 7.14 %) |
||||
| Open | High | Low | Volume | ||
| 0.7¢ | 0.8¢ | 0.7¢ | 1800000 | ||
| Last updated 13.50pm 22/05/2024 ? | |||||
| PAB (ASX) Chart |